Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
February 25 2015 - 5:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-31886
AXM PHARMA,
INC.
(Exact name of registrant as specified in its
charter)
1055 W. 7th St.
33rd Floor
Los Angeles, California 90017
(213) 986-4969
(Address, including zip code, and telephone
number, including area code, of registrant's principal executive offices)
Common Stock, $0.001 par value
(Title of each class of securities covered by
this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) [ ]
Rule 12g-4(a)(2) [X]
Rule 12h-3(b)(1)(i) [ ]
Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6
[ ]
|
Approximate number of holders of record as of the certification
or notice date: one hundred and thirty three (133).
Pursuant to the requirements of the
Securities Exchange Act of 1934, AXM Pharma, Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
Date: February 25, 2015 |
By: /s/ Joseph Arcaro |
|
Joseph Arcaro, Chief Executive Officer |
AXM Pharma (CE) (USOTC:AXMP)
Historical Stock Chart
From Sep 2024 to Oct 2024
AXM Pharma (CE) (USOTC:AXMP)
Historical Stock Chart
From Oct 2023 to Oct 2024